On the above basis, and given the ability of BAT to dissipate energy as heat and to contribute to EE, we are optimistic that melatonin can be used as a BAT activator for future therapeutic applications in obesity. This evidence concerns the gene BAAT and obesity due to melanocortin 4 receptor deficiency.